Several arenavirus pathogens, such as Lassa and Junin viruses, inhibit macrophage activation, the molecular mechanism of which is unclear. We show that lymphocytic choriomeningitis virus (LCMV) can also inhibit macrophage activation, in contrast to Pichinde and Tacaribe viruses, which are not known to naturally cause human diseases. Using a recombinant Pichinde virus system, we show that the LCMV Z N-terminal domain (NTD) mediates the inhibition of macrophage activation and immune functions.A renaviruses include several hemorrhagic fever (HF)-causing agents, such as Lassa fever virus (LASV) and Junin virus (JUNV), with limited preventative or therapeutic measures (1, 2). Arenavirus pathogenesis is associated with high viremia and generalized immune suppression, the mechanism of which is poorly understood (3, 4). Macrophages and dendritic cells (DCs) are the early target cells of arenavirus infections. Activated macrophages and DCs play important roles in both innate and adaptive immunity (5, 6). Several studies have shown that LASV and JUNV, but not their nonpathogenic counterparts Mopeia virus (MOPV) and Tacaribe virus (TCRV), can inhibit human macrophage activation (7-10), the molecular mechanism of which is unknown. As all arenaviruses encode a conserved nucleoprotein (NP) RNase with activity to block the interferon (IFN) induction (11-18), it seems unlikely that NP mediates the differential inhibition of macrophages by various arenaviruses. We have recently found that the Z proteins from known arenavirus pathogens, including HF-causing LASV and JUNV as well as lymphocytic choriomeningitis virus (LCMV), that can cause neurologic diseases (19), but not those from others, such as TCRV and Pichinde virus (PICV), which have not been associated with significant human diseases (20, 21), can inhibit RIG-i/MDA5 and block the RIG-i-like-receptor (RLR)-dependent IFN production in macrophages and that the differential RLR inhibition is determined by the N-terminal domain (NTD) (22).To determine whether this newly discovered Z NTD-mediated RLR inhibition contributes to the differential inhibition of human macrophages by distinct arenaviruses, we analyzed the macrophage activation upon infection with LCMV, TCRV, PICV (both the P2 and the P18 strains), or a recombinant PICV encoding a chimeric Z protein with the 31-residue NTD from LCMV (rP18-ZN LCMV ) (22). Human monocyte-derived macrophages (hMDMs) were obtained as described previously (22) and treated with lipopolysaccharide (LPS) for 6 h or infected with the aforementioned arenaviruses at a multiplicity of infection (MOI) of 2 for 1 and 3 days. The infection rate was nearly 100% for each virus as demonstrated by the intracellular immunofluorescence staining of viral NP with anti-NP antibody (Fig. 1A). Macrophage activation was first assessed by flow cytometric analysis of the surface expression of CD80 and CD86, the two established macrophage activation markers and costimulatory molecules.LPS, a known strong inducer of macrophage activation, caused substantial increase...